As YAP hyperactivity has been characterized as essential in several human tumor types, including breast cancer (Zanconato et al., 2016), it follows that cancer cell lines with lower CLK2 activity may display increased aggressiveness by activating YAP through the splicing-based mechanism presented here. The gene discussed is YAP1; the disease is neoplasm.